CXCL14 and Hepatic fibrosis: CXCL14 is a recently discovered member of the CXC chemokine family (Lu et al., 2016), whose overexpression remarkably aggravates CCl4-induced liver injury, making it a potential therapeutic target for liver fibrosis (Li et al., 2011; Wang et al., 2020).